Pressure On CMS To Add UDI To Claims Forms Continues
This article was originally published in The Gray Sheet
Executive Summary
The West Health Institute has joined a group of stakeholders calling for incorporating Unique Device Identifier codes in reimbursement claims forms to improve postmarket surveillance. But hospital and physician groups continue to push against the notion, stating it would create unnecessary burdens.
You may also be interested in...
Leveraging Registries: A Next Step In National Post-Market Plan
FDA is making a major push as part of its new post-market surveillance strategy to make better use of existing national patient registries, while avoiding imposition of additional mandatory device registries.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.